Market Cap ₹264 Cr.
Stock P/E 0.0
P/B 3.1
Current Price ₹135
Book Value ₹ 43.3
Face Value 10
52W High ₹236
Dividend Yield 0%
52W Low ₹ 100
Paragon Fine and Specialty Chemical Ltd is a distinguished company at the forefront of chemical manufacturing and innovation. Renowned for its commitment to quality and excellence, Paragon specializes in producing a diverse range of fine and specialty chemicals tailored to meet the unique needs of various industries. With state-of-the-art facilities and a team of skilled professionals, the company consistently delivers cutting-edge solutions and customized products to its global clientele. Paragon places a strong emphasis on sustainable practices, ensuring its operations align with environmental standards. As a market leader, Paragon Fine and Specialty Chemical Ltd continues to set industry benchmarks, providing reliable and high-performance chemical solutions for a wide array of applications.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|
Net Sales | 83 | 83 | 102 | |
Other Income | 1 | 2 | 3 | |
Total Income | 84 | 85 | 105 | |
Total Expenditure | 77 | 77 | 89 | |
Operating Profit | 7 | 8 | 16 | |
Interest | 1 | 1 | 1 | |
Depreciation | 1 | 1 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | |
Profit Before Tax | 6 | 6 | 14 | |
Provision for Tax | 2 | 2 | 4 | |
Profit After Tax | 4 | 4 | 10 | |
Adjustments | 0 | 0 | 0 | |
Profit After Adjustments | 4 | 4 | 10 | |
Adjusted Earnings Per Share | 3.1 | 3.1 | 6.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 23% | 0% | 0% | 0% |
Operating Profit CAGR | 100% | 0% | 0% | 0% |
PAT CAGR | 150% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 57% | 52% | 52% | 52% |
ROCE Average | 37% | 27% | 27% | 27% |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|
Shareholder's Funds | 8 | 12 | 22 |
Minority's Interest | 0 | 0 | 0 |
Borrowings | 12 | 14 | 14 |
Other Non-Current Liabilities | 0 | 0 | 0 |
Total Current Liabilities | 30 | 31 | 34 |
Total Liabilities | 50 | 58 | 71 |
Fixed Assets | 7 | 10 | 9 |
Other Non-Current Assets | 0 | 1 | 1 |
Total Current Assets | 43 | 47 | 61 |
Total Assets | 50 | 58 | 71 |
#(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|
Opening Cash & Cash Equivalents | 2 | 1 | 1 |
Cash Flow from Operating Activities | -9 | 5 | -2 |
Cash Flow from Investing Activities | -1 | -4 | -1 |
Cash Flow from Financing Activities | 9 | -2 | 3 |
Net Cash Inflow / Outflow | -1 | -1 | 1 |
Closing Cash & Cash Equivalent | 1 | 1 | 1 |
# | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|
Earnings Per Share (Rs) | 3.05 | 3.12 | 6.87 |
CEPS(Rs) | 3.47 | 3.6 | 7.44 |
DPS(Rs) | 0 | 0 | 0 |
Book NAV/Share(Rs) | 5.52 | 8.64 | 15.51 |
Core EBITDA Margin(%) | 7.62 | 7.16 | 12.55 |
EBIT Margin(%) | 8.23 | 8.43 | 14.43 |
Pre Tax Margin(%) | 7.24 | 7.45 | 13.26 |
PAT Margin (%) | 5.28 | 5.42 | 9.67 |
Cash Profit Margin (%) | 6.01 | 6.27 | 10.48 |
ROA(%) | 8.82 | 8.37 | 15.4 |
ROE(%) | 55.3 | 44.03 | 56.89 |
ROCE(%) | 22.94 | 22.17 | 36.58 |
Receivable days | 129.51 | 112.61 | 86.87 |
Inventory Days | 6.16 | 31 | 62.32 |
Payable days | 93.41 | 116.14 | 95.41 |
PER(x) | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 |
EV/Net Sales(x) | 0.25 | 0.24 | 0.27 |
EV/Core EBITDA(x) | 2.78 | 2.63 | 1.77 |
Net Sales Growth(%) | 0 | -0.51 | 23.47 |
EBIT Growth(%) | 0 | 1.86 | 111.27 |
PAT Growth(%) | 0 | 2.1 | 120.3 |
EPS Growth(%) | 0 | 2.1 | 120.3 |
Debt/Equity(x) | 2.76 | 1.66 | 1.13 |
Current Ratio(x) | 1.44 | 1.53 | 1.81 |
Quick Ratio(x) | 1.39 | 1.12 | 1.15 |
Interest Cover(x) | 8.27 | 8.6 | 12.42 |
Total Debt/Mcap(x) | 0 | 0 | 0 |
# | Mar 2024 |
---|---|
Promoter | 74.59 |
FII | 2.04 |
DII | 2.37 |
Public | 20.99 |
Others | 0 |
Total | 100 |
# | Mar 2024 |
---|---|
Promoter | 1.46 |
FII | 0.04 |
DII | 0.05 |
Public | 0.41 |
Others | 0 |
Total | 1.96 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About